Skip to main content



Dry Eye or MGD?

It’s time to change your outlook on dry eye.

There are approximately 30 million individuals living in the United States, and more than 300 million worldwide who have been diagnosed with dry eye. People suffering with dry eye are generally offered eye drops or other treatment techniques that only offer temporary symptom relief. Only recently have doctors understood that the underlying problem of most dry eyes (86%) is an interminable and dynamic condition, Meibomian Gland Dysfunction or MGD.

MGD happens when the meibomian glands in the eyelids that create the defensive slick layer of the tear film become blocked. These organs can become blocked over time and, then they can no longer create the necessary oils required for solid tears. This blockage brings about fast dissipation of your tears and leads to irritation, discomfort, and if not treated, gland dropout.

How is MGD Diagnosed?

Your eye doctor will perform several tests to determine if you have MGD. These tests may include a LipiView® tear film and gland imaging test, and a meibomian gland evaluation. Once your doctor understands what is causing your Dry Eye, he or she will be able to determine the best treatment option.

Now, with the breakthrough LipiFlow® technology, it’s possible to directly treat the root cause of MGD!

Treating MGD with LipiFlow

LipiFlow ® is a new treatment for dry eye that restores the lipid layer of the tear film, so the tears function better. While there are multiple choices available for treating MGD, LipiFlow is the only FDA-approved treatment for removing gland blockages and restoring gland function.

Developed by TearScience, the sterile lid warmer and eyecup apply a combination of heat and pressure to the eyes for less than 15 minutes at a time, under constant monitoring by an eye doctor. The procedure is not painful, and enables the tear glands to secrete good quality tears, and is done in the comfort of your optometrist’s office.

mgd lipiflow.jpg